Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
University of Pittsburgh
University of Pittsburgh
University of Pittsburgh
University of Chicago
Istituto Oncologico Veneto IRCCS
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Hôpital NOVO
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dutch Society of Physicians for Pulmonology and Tuberculosis
M.D. Anderson Cancer Center
Seoul National University Bundang Hospital
Azienda Ospedaliero-Universitaria di Parma
UNC Lineberger Comprehensive Cancer Center
University of Colorado, Denver
University of Pittsburgh
Institut de Cancérologie de Lorraine
Mayo Clinic
Memorial Sloan Kettering Cancer Center
University of Chicago
Radboud University Medical Center
New York University
Universitair Ziekenhuis Brussel
Insel Gruppe AG, University Hospital Bern
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
Samsung Medical Center
Bruce Robinson, MD
Geisinger Clinic
Dana-Farber Cancer Institute
University of Pittsburgh
University of Pittsburgh
Indiana University
Gustave Roussy, Cancer Campus, Grand Paris
Abramson Cancer Center at Penn Medicine
UNC Lineberger Comprehensive Cancer Center
Stanford University
Stony Brook University
Gruppo Oncologico del Nord-Ovest
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Women's College Hospital
Imperial College London
Aalborg University Hospital
University of California, San Francisco
UNICANCER
The Center for Clinical and Cosmetic Research
National Taiwan University Hospital
Sun Yat-sen University